WORCESTER, Mass., June 4, 2009 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, today announced that data in respect of two of its products will be presented at the American Diabetes Association's (ADA's) 69th Annual Scientific Sessions being held in New Orleans from June 5 to 9. The annual meeting of the ADA (www.diabetes.org) is one of the largest scientific meetings for endocrinologists and other health care professionals involved in diabetes research and diabetes care.
